Trials / Completed
CompletedNCT04597268
Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures
Safety and Efficacy of Dexmedetomidine vs Ketamine vs Midazolam Combined With Propofol in Gastrointestinal Procedures for Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the safety and efficacy of dexmedetomidine versus ketamine versus midazolam combined with propofol in cancer patients undergoing gastrointestinal endoscopic procedures.
Detailed description
Comparison between using intravenous (IV) propofol combined with either IV dexmedetomidine or IV ketamine or IV midazolam; to study the effect of their combination on level of sedation and hemodynamic stability on adult patients scheduled for gastrointestinal endoscopic procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | intravenous dexmedetomidine 1 mic/kg |
| DRUG | Ketamine | ketamine 1mg/kg |
| DRUG | Midazolam | midazolam 0.05 mg/kg |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2022-12-15
- Completion
- 2022-12-30
- First posted
- 2020-10-22
- Last updated
- 2023-01-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04597268. Inclusion in this directory is not an endorsement.